Lilly drug slows Alzheimer's in some, fails main goals
NEW YORK/CHICAGO (Reuters) - Eli Lilly and Co said its experimental Alzheimer's drug showed signs of slowing mental decline in patients with a mild form of the disease, even though it failed to meet...
No comments:
Post a Comment